Introduction
The bactericidal/permeability-increasing protein (BPI) is a cationic antimicrobial protein produced by polymorphonuclear leukocytes. BPI specifically interacts with and kills Gram-negative bacteria. BPI binds to the lipopolysaccharide (LPS) component of the outer membrane of Gram-negative bacteria, increases membrane permeability to hydrophobic substances and causes irreversible loss of bacterial cell homeostasis. [1] [2] [3] [4] [5] [6] BPI competes with lipopolysaccharide-binding protein (LBP) secreted by liver cells into the blood plasma for binding to LPS. 7-m In this way BPI reduces the proinflammatory effects of gps. [11] [12] [13] [14] [15] [16] [17] [18] [19] Because there is potential anti-infectious ther- There was a positive correlation between the concentration of BPI in serum and the white blood cell count (r 0.589, p < 0.0001, n--83) (Fig. 3) . There was also a positive correlation between serum BPI and CRP levels (r 0.39, p < 0.05, n 59 In conclusion, the concentration of BPI can be measured reliably in human serum by timeresolved fluoroimmunoassay.
